The non-hormonal drug fezolinetant, marketed by Astellas under the name Veoza, alleviates vasomotor symptoms (VMS) – also known as hot flushes and night sweats – that many women suffer from during...
Women's health
Update on travel vaccinations, the 2024 flu programme, improving immunisation update in practice and dealing with vaccine hesitancy.
Highlights of the programme include tackling the overuse of reliever inhalers for asthma, providing greener respiratory care, managing allergic rhinitis and a look at the use of rescue packs in COPD.
Today's most viewed content
Register to get a FREE issue of Practice Nursing, including articles on asthma, diabetes and much more.
